
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>abmd-10k 20170331.htm</i></p>
<p style="font-size: small; color: grey;"><i>Page 60 of 83</i></p>
<p style="font-size: small; color: grey;"><i>ABIOMED_10k_060.pdf</i></p>
<p>ABIOMED, INC. AND SUBSIDIARIES Consolidated Statements of Stockholders&#x27; Equity (dollars in thousands)</p>

<table>
	<tr>
		<th rowspan="2"></th>
		<th colspan="2">Common Stock</th>
		<th colspan="2">Treasury Stock</th>
		<th rowspan="2">Additional Paid in Capital</th>
		<th rowspan="2">Accumulated Deficit</th>
		<th rowspan="2">Accumulated Other Comprehensive Income (Loss)</th>
		<th rowspan="2">Total Stockholders&#x27; Equity</th>
	</tr>
	<tr>
		<th>Number of shares</th>
		<th>Par value</th>
		<th>Number of shares</th>
		<th>Amount</th>
	</tr>
	<tr>
		<td>Balance, March 31, 2014</td>
		<td>39,916,328</td>
		<td>$ 411</td>
		<td>1,206,367</td>
		<td>$ (16,554)</td>
		<td>$ 436,136</td>
		<td>$ (250,910)</td>
		<td>$ (730)</td>
		<td>$ 168,353</td>
	</tr>
	<tr>
		<td>Restricted stock units issued</td>
		<td>543,420</td>
		<td>5</td>
		<td>-</td>
		<td>-</td>
		<td>(5)</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
	</tr>
	<tr>
		<td>Stock options exercised</td>
		<td>911,553</td>
		<td>9</td>
		<td>-</td>
		<td>-</td>
		<td>10,918</td>
		<td>-</td>
		<td>-</td>
		<td>10,927</td>
	</tr>
	<tr>
		<td>Stock issued under employee stock purchase plan</td>
		<td>39,095</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>795</td>
		<td>-</td>
		<td>-</td>
		<td>795</td>
	</tr>
	<tr>
		<td>Stock issued to directors</td>
		<td>1,954</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>76</td>
		<td>-</td>
		<td>-</td>
		<td>76</td>
	</tr>
	<tr>
		<td>Return of common stock to pay withholding taxes on restricted stock</td>
		<td>(76,577)</td>
		<td>(12)</td>
		<td>76,577</td>
		<td>(2,793)</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>(2,805)</td>
	</tr>
	<tr>
		<td>Stock compensation expense</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>16,520</td>
		<td>-</td>
		<td>-</td>
		<td>16,520</td>
	</tr>
	<tr>
		<td>Excess tax benefit from stock-based awards</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>606</td>
		<td>-</td>
		<td>-</td>
		<td>606</td>
	</tr>
	<tr>
		<td>Other comprehensive loss</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>(16,600)</td>
		<td>(16,600)</td>
	</tr>
	<tr>
		<td>Net income</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>113,688</td>
		<td>-</td>
		<td>113,688</td>
	</tr>
	<tr>
		<td>Balance, March 31, 2015</td>
		<td>41,335,773</td>
		<td>$ 413</td>
		<td>1,282,944</td>
		<td>$ (19,347</td>
		<td>$ 465,046</td>
		<td>S $ (137,222)</td>
		<td>$ (17,330)</td>
		<td>$ 291,560</td>
	</tr>
	<tr>
		<td>Restricted stock units issued</td>
		<td>507,471</td>
		<td>5</td>
		<td>-</td>
		<td>-</td>
		<td>(5)</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
	</tr>
	<tr>
		<td>Stock options exercised</td>
		<td>829,385</td>
		<td>8</td>
		<td>-</td>
		<td>-</td>
		<td>9,763</td>
		<td>-</td>
		<td>-</td>
		<td>9,771</td>
	</tr>
	<tr>
		<td>Stock issued under employee stock purchase plan</td>
		<td>16,772</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>1,135</td>
		<td>-</td>
		<td>-</td>
		<td>1,135</td>
	</tr>
	<tr>
		<td>Stock issued to directors</td>
		<td>774</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>65</td>
		<td>-</td>
		<td>-</td>
		<td>65</td>
	</tr>
	<tr>
		<td>Return of common stock to pay withholding taxes on restricted stock</td>
		<td>(93,947)</td>
		<td>-</td>
		<td>93,947</td>
		<td>(7,313)</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>(7,313)</td>
	</tr>
	<tr>
		<td>Stock compensation expense</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>29,053</td>
		<td>-</td>
		<td>-</td>
		<td>29,053</td>
	</tr>
	<tr>
		<td>Excess tax benefit from stock-based awards</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>3,567</td>
		<td>-</td>
		<td>-</td>
		<td>3,567</td>
	</tr>
	<tr>
		<td>Other comprehensive income</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>2,790</td>
		<td>2,790</td>
	</tr>
	<tr>
		<td>Net income</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>38,147</td>
		<td>-</td>
		<td>38,147</td>
	</tr>
	<tr>
		<td>Balance, March 31, 2016</td>
		<td>42,596,228</td>
		<td>$ 426</td>
		<td>1,376,891</td>
		<td>$ (26,660)</td>
		<td>$ 508,624</td>
		<td>$ (99,075)</td>
		<td>$ (14,540)</td>
		<td>$ 368,775</td>
	</tr>
	<tr>
		<td>Restricted stock units issued</td>
		<td>502,417</td>
		<td>5</td>
		<td>-</td>
		<td>-</td>
		<td>(5)</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
	</tr>
	<tr>
		<td>Stock options exercised</td>
		<td>754,893</td>
		<td>8</td>
		<td>-</td>
		<td>-</td>
		<td>10,652</td>
		<td>-</td>
		<td>-</td>
		<td>10,660</td>
	</tr>
	<tr>
		<td>Stock issued under employee stock purchase plan</td>
		<td>18,288</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>1,720</td>
		<td>-</td>
		<td>-</td>
		<td>1,720</td>
	</tr>
	<tr>
		<td>Stock issued to directors</td>
		<td>564</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>67</td>
		<td>-</td>
		<td>-</td>
		<td>67</td>
	</tr>
	<tr>
		<td>Return of common stock to pay withholding taxes on restricted stock</td>
		<td>(199,104)</td>
		<td>(2)</td>
		<td>199,104</td>
		<td>(20,103)</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>(20,105)</td>
	</tr>
	<tr>
		<td>Stock compensation expense</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>32,866</td>
		<td>-</td>
		<td>-</td>
		<td>32,866</td>
	</tr>
	<tr>
		<td>Excess tax benefit from stock-based awards</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>12,038</td>
		<td>-</td>
		<td>-</td>
		<td>12,038</td>
	</tr>
	<tr>
		<td>Other comprehensive loss</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>(6,066)</td>
		<td>(6,066)</td>
	</tr>
	<tr>
		<td>Net income</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>-</td>
		<td>52,116</td>
		<td>-</td>
		<td>52,116</td>
	</tr>
	<tr>
		<td>Balance, March 31, 2017</td>
		<td>43,673,286</td>
		<td>$ 437</td>
		<td>1,575,995</td>
		<td>$ (46,763</td>
		<td>$ 565,962</td>
		<td>$ (46,959</td>
		<td>$ (20,606)</td>
		<td>S 452,071</td>
	</tr>
</table>
<p>The accompanying notes are an integral part of the consolidated financial statements.</p>
<p style="font-size: small; color: grey;"><i>F-6</i></p>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/HealthCare/ ... 7/23/2018</i></p>

</body>
</html>
